Skip to Content

BBS-Bioactive Bone Substitutes PLC Ordinary Shares Stock Quote BONEH

Rating as of

Morningstar's BBS-Bioactive Bone Substitutes PLC Ordinary Shares Stock Analysis

Valuation
Currency in EUR
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - BONEH

Company Profile - BONEH

Business Description

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures innovative bioactive bone-graft substitute implants. Its ortho biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

Contact
Kiviharjunlenkki 6
Oulu, 90220, Finland
T +358 407080307
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Dec 31, 2022
Stock Type
Employees 17